199 related articles for article (PubMed ID: 37101162)
1. Diagnostic value of neutrophil gelatinase-associated lipocalin (NGAL) as an early biomarker for detection of renal failure in hypertensives: a case-control study in a regional hospital in Ghana.
Danquah M; Owiredu WKBA; Jnr BAE; Serwaa D; Odame Anto E; Peprah MO; Obirikorang C; Fondjo LA
BMC Nephrol; 2023 Apr; 24(1):114. PubMed ID: 37101162
[TBL] [Abstract][Full Text] [Related]
2. Comparative assessment of neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C as early biomarkers for early detection of renal failure in patients with hypertension.
Gharishvandi F; Kazerouni F; Ghanei E; Rahimipour A; Nasiri M
Iran Biomed J; 2015; 19(2):76-81. PubMed ID: 25864811
[TBL] [Abstract][Full Text] [Related]
3. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease.
Malyszko J; Bachorzewska-Gajewska H; Malyszko JS; Pawlak K; Dobrzycki S
Nephrology (Carlton); 2008 Apr; 13(2):153-6. PubMed ID: 18275504
[TBL] [Abstract][Full Text] [Related]
4. Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in heart allograft recipients.
Przybylowski P; Malyszko J; Malyszko JS
Transplant Proc; 2010 Jun; 42(5):1797-802. PubMed ID: 20620526
[TBL] [Abstract][Full Text] [Related]
5. Kidney function assessed by eGFR, cystatin C and NGAL (neutrophil gelatinase-associated lipocalin) in relation to age in heart allograft recipients.
Przybylowski P; Malyszko J; Malyszko J
Med Sci Monit; 2010 Sep; 16(9):CR440-4. PubMed ID: 20802417
[TBL] [Abstract][Full Text] [Related]
6. Plasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy.
Park GY; Yu CH; Kim JS; Kang YJ; Kwon O; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
Korean J Intern Med; 2015 May; 30(3):345-53. PubMed ID: 25995665
[TBL] [Abstract][Full Text] [Related]
7. Implications of the changes in serum neutrophil gelatinase-associated lipocalin and cystatin C in patients with chronic kidney disease.
Shen SJ; Hu ZX; Li QH; Wang SM; Song CJ; Wu DD; He JL; Guan JC; Shan JP
Nephrology (Carlton); 2014 Mar; 19(3):129-35. PubMed ID: 24397346
[TBL] [Abstract][Full Text] [Related]
8. Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification.
Xiang D; Zhang H; Bai J; Ma J; Li M; Gao J; Wang C
Int J Clin Exp Pathol; 2014; 7(10):7172-81. PubMed ID: 25400814
[TBL] [Abstract][Full Text] [Related]
9. Importance of urinary NGAL, serum creatinine standardization and estimated glomerular filtration rate in resistant hypertension.
Prkacin I; Ozvald I; Cavrić G; Balenović D; Bulum T; Flegar-Mestrić Z
Coll Antropol; 2013 Sep; 37(3):821-5. PubMed ID: 24308223
[TBL] [Abstract][Full Text] [Related]
10. Plasma neutrophil gelatinase-associated lipocalin and kidney function decline and kidney disease-related clinical events in older women.
Lim WH; Lewis JR; Wong G; Teo R; Lim EM; Byrnes E; Prince RL
Am J Nephrol; 2015; 41(2):156-64. PubMed ID: 25824561
[TBL] [Abstract][Full Text] [Related]
11. Plasma Neutrophil Gelatinase-Associated Lipocalin Associates with New-Onset Chronic Kidney Disease in the General Population.
Bourgonje AR; Abdulle AE; Bourgonje MF; Kieneker LM; la Bastide-van Gemert S; Gordijn SJ; Hidden C; Nilsen T; Gansevoort RT; Mulder DJ; Dullaart RPF; de Borst MH; Bakker SJL; van Goor H
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830706
[TBL] [Abstract][Full Text] [Related]
12. Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study.
Liu KD; Yang W; Go AS; Anderson AH; Feldman HI; Fischer MJ; He J; Kallem RR; Kusek JW; Master SR; Miller ER; Rosas SE; Steigerwalt S; Tao K; Weir MR; Hsu CY;
Am J Kidney Dis; 2015 Feb; 65(2):267-74. PubMed ID: 25311702
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients.
Malyszko J; Malyszko JS; Bachorzewska-Gajewska H; Poniatowski B; Dobrzycki S; Mysliwiec M
Transplant Proc; 2009; 41(1):158-61. PubMed ID: 19249502
[TBL] [Abstract][Full Text] [Related]
14. Effect of glomerular filtration rate impairment on diagnostic performance of neutrophil gelatinase-associated lipocalin and B-type natriuretic peptide as markers of acute cardiac and renal failure in chronic kidney disease patients.
Donadio C
Crit Care; 2014 Feb; 18(1):R39. PubMed ID: 24581340
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil gelatinase-associated lipocalin as a biomarker of renal impairment in patients with multiple myeloma.
Chae H; Ryu H; Cha K; Kim M; Kim Y; Min CK
Clin Lymphoma Myeloma Leuk; 2015 Jan; 15(1):35-40. PubMed ID: 25204517
[TBL] [Abstract][Full Text] [Related]
16. The application of neutrophil gelatin-related lipid delivery protein in evaluation of renal function, nutrition, anemia and inflammation in patients with CKD.
Gu Z; Huang Y; Yang F; Tang S; Sun J; Chen T; Liu F; Wu H; Wang J
Nephrol Ther; 2021 Feb; 17(1):35-41. PubMed ID: 33468440
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease.
Bolignano D; Lacquaniti A; Coppolino G; Campo S; Arena A; Buemi M
Kidney Blood Press Res; 2008; 31(4):255-8. PubMed ID: 18600028
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of contrast-induced nephropathy after percutaneous coronary intervention.
Liebetrau C; Gaede L; Doerr O; Blumenstein J; Rixe J; Teichert O; Willmer M; Weber M; Rolf A; Möllmann H; Hamm C; Nef H
Scand J Clin Lab Invest; 2014 Mar; 74(2):81-8. PubMed ID: 24304491
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil gelatinase-associated lipocalin and end-stage renal disease: it is not all about the kidneys!
Rau S; Habicht A; Kauke T; Hillmer A; Wessely M; Stangl M; Guba M; Fischereder M; Schönermarck U
Eur J Clin Invest; 2013 Aug; 43(8):816-20. PubMed ID: 23710757
[TBL] [Abstract][Full Text] [Related]
20. Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease.
Liu KD; Yang W; Anderson AH; Feldman HI; Demirjian S; Hamano T; He J; Lash J; Lustigova E; Rosas SE; Simonson MS; Tao K; Hsu CY;
Kidney Int; 2013 May; 83(5):909-14. PubMed ID: 23344473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
